Regular follow-ups are integral to tailoring the GLP-1 therapy to meet individual patient needs, adjusting dosages, and monitoring progress
The initiative has been dubbed Medicare GLP-1 Bridge. GLP-1s can be life-changing for patients managing obesity and related conditions, Chris Klomp, Director of Medicare and Chief Counselor at the U.S
A 2025 University of British Columbia study found that women taking semaglutide had more than double the risk of hair loss compared to women on alternative weight loss medication
Rotem A, Janzer A, Izar B, Ji Z, Doench JG, Garraway LA, et al
Its scientific relevance comes from the way one molecular structure can be examined across multiple receptor families that participate in metabolic signaling, cellular communication, and pathway-level regulation